Pages that link to "Q34124945"
Jump to navigation
Jump to search
The following pages link to Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. (Q34124945):
Displaying 50 items.
- Current challenges and novel treatment strategies in double hit lymphomas (Q26770385) (← links)
- Functional Significance of Aurora Kinases-p53 Protein Family Interactions in Cancer (Q28071615) (← links)
- Drugging the addict: non-oncogene addiction as a target for cancer therapy (Q28079559) (← links)
- Transcriptional control of mitosis: deregulation and cancer (Q28082114) (← links)
- Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition (Q28396027) (← links)
- Inhibition of Aurora kinase B is important for biologic activity of the dual inhibitors of BCR-ABL and Aurora kinases R763/AS703569 and PHA-739358 in BCR-ABL transformed cells (Q28545195) (← links)
- Selective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs (Q28547522) (← links)
- Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors (Q28817295) (← links)
- SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers (Q28818608) (← links)
- MYC on the path to cancer (Q29619979) (← links)
- Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulation (Q33390573) (← links)
- Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas (Q33410380) (← links)
- Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108. (Q33423638) (← links)
- Three steps to the immortality of cancer cells: senescence, polyploidy and self-renewal (Q33590178) (← links)
- Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer (Q33604452) (← links)
- Aurora kinases: novel therapy targets in cancers (Q33618929) (← links)
- Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma (Q33709521) (← links)
- SIX3, a tumor suppressor, inhibits astrocytoma tumorigenesis by transcriptional repression of AURKA/B. (Q33781657) (← links)
- Comparison of selected gene expression profiles in sensitive and resistant cancer cells treated with doxorubicin and Selol (Q33799201) (← links)
- Small cell lung cancer: where do we go from here? (Q33872327) (← links)
- The ARF tumor suppressor prevents chromosomal instability and ensures mitotic checkpoint fidelity through regulation of Aurora B. (Q34166850) (← links)
- Cks1 is required for tumor cell proliferation but not sufficient to induce hematopoietic malignancies (Q34279980) (← links)
- Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma (Q34293007) (← links)
- Visual gene-network analysis reveals the cancer gene co-expression in human endometrial cancer (Q34525508) (← links)
- Update on aurora kinase inhibitors in gynecologic malignancies (Q34576017) (← links)
- Targeting the MYC and PI3K pathways eliminates leukemia-initiating cells in T-cell acute lymphoblastic leukemia (Q34645214) (← links)
- Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions. (Q34654508) (← links)
- Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma (Q34780881) (← links)
- Update on aurora kinase targeted therapeutics in oncology (Q34941504) (← links)
- GP130 activation induces myeloma and collaborates with MYC. (Q35145350) (← links)
- Alisertib added to rituximab and vincristine is synthetic lethal and potentially curative in mice with aggressive DLBCL co-overexpressing MYC and BCL2. (Q35180822) (← links)
- Site-specific programming of the host epithelial transcriptome by the gut microbiota (Q35500118) (← links)
- Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma. (Q35550246) (← links)
- Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck (Q35640310) (← links)
- Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models. (Q35745893) (← links)
- Direct and indirect targeting of MYC to treat acute myeloid leukemia (Q35798798) (← links)
- Small cell lung cancer: will recent progress lead to improved outcomes? (Q35836257) (← links)
- Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas (Q35859974) (← links)
- MYC Is a Major Determinant of Mitotic Cell Fate (Q35898987) (← links)
- Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation (Q35954892) (← links)
- Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma. (Q36078222) (← links)
- Strategies to Inhibit Myc and Their Clinical Applicability (Q36303678) (← links)
- Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression (Q36331863) (← links)
- Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. (Q36359558) (← links)
- Aurora kinase targeting in lung cancer reduces KRAS-induced transformation (Q36538710) (← links)
- Can immunotherapy specifically target acute myeloid leukemic stem cells? (Q36694901) (← links)
- Aurora A kinase (AURKA) in normal and pathological cell division (Q36715681) (← links)
- Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management (Q36738463) (← links)
- Targeting MYC in cancer therapy: RNA processing offers new opportunities (Q36762189) (← links)
- Aberrant overexpression of IL-15 initiates large granular lymphocyte leukemia through chromosomal instability and DNA hypermethylation (Q36768723) (← links)